Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.

BACKGROUND: Mirtazapine has a unique mechanism of antidepressant action, and thus is thought to have a different profile of adverse events from that of other antidepressants. OBJECTIVE: To present a methodologically rigorous systematic review of the adverse event profile of mirtazapine and point to...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Watanabe, N, Omori, I, Nakagawa, A, Cipriani, A, Barbui, C, McGuire, H, Churchill, R, Furukawa, T
Natura:	Journal article
Lingua:	English
Pubblicazione:	2010

Documenti analoghi

Mirtazapine versus other antidepressive agents for depression.
di: Watanabe, N, et al.
Pubblicazione: (2011)

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
di: Watanabe, N, et al.
Pubblicazione: (2008)

Milnacipran versus other antidepressive agents for depression.
di: Nakagawa, A, et al.
Pubblicazione: (2009)

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.
di: Nakagawa, A, et al.
Pubblicazione: (2008)

Escitalopram versus other antidepressive agents for depression.
di: Cipriani, A, et al.
Pubblicazione: (2009)

Sertraline versus other antidepressive agents for depression.
di: Cipriani, A, et al.
Pubblicazione: (2009)

Sertraline versus other antidepressive agents for depression.
di: Cipriani, A, et al.
Pubblicazione: (2010)

Sertraline versus other antidepressive agents for depression
di: Cipriani, A, et al.
Pubblicazione: (2010)

Fluvoxamine versus other anti-depressive agents for depression.
di: Omori, I, et al.
Pubblicazione: (2010)

Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis.
di: Omori, I, et al.
Pubblicazione: (2009)

Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
di: Cipriani, A, et al.
Pubblicazione: (2008)

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.
di: Cipriani, A, et al.
Pubblicazione: (2009)

Making the best use of available evidence: the case of new generation antidepressants: a response to: are all antidepressants equal?
di: Barbui, C, et al.
Pubblicazione: (2009)

Suicide, depression, and antidepressants.
di: Cipriani, A, et al.
Pubblicazione: (2005)

Long-term treatment of depression with antidepressants: a systematic narrative review.
di: Furukawa, T, et al.
Pubblicazione: (2007)

Citalopram versus other anti-depressive agents for depression.
di: Cipriani, A, et al.
Pubblicazione: (2012)

Antidepressants in Alzheimer’s Disease: A Focus on the Role of Mirtazapine
di: Ana Salomé Correia, et al.
Pubblicazione: (2021-09-01)

Duloxetine versus other anti-depressive agents for depression.
di: Cipriani, A, et al.
Pubblicazione: (2012)

Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.
di: Cipriani, A, et al.
Pubblicazione: (2007)

Ranking antidepressants Reply
di: Cipriani, A, et al.
Pubblicazione: (2009)

Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis
di: Furukawa, T, et al.
Pubblicazione: (2019)

Is the efficacy of antidepressants in panic disorder mediated by adverse events? A mediational analysis.
di: Irene Bighelli, et al.
Pubblicazione: (2017-01-01)

Suicide, depression, and antidepressants - Patients and clinicians need to balance benefits and harms
di: Cipriani, A, et al.
Pubblicazione: (2005)

Trazodone Addition to Paroxetine and Mirtazapine in a Patient with Treatment-Resistant Depression: The Pros and Cons of Combining Three Antidepressants
di: Rui Lopes, et al.
Pubblicazione: (2016-01-01)

The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis
di: Caroline Barkholt Kamp, et al.
Pubblicazione: (2025-01-01)

The history of mianserin and mirtazapine: study of their neurochemical activity and determination of their position in the classification of antidepressants
di: D. S. Danilov, et al.
Pubblicazione: (2020-04-01)

Formulation of Intranasal Mucoadhesive Thermotriggered In Situ Gel Containing Mirtazapine as an Antidepressant Drug
di: Mohammed Ghazwani, et al.
Pubblicazione: (2023-06-01)

Environmentally relevant concentrations of antidepressant mirtazapine impair the neurodevelopment of zebrafish (Danio rerio)
di: Jie Zhou, et al.
Pubblicazione: (2023-09-01)

Determination of the antidepressant effect of mirtazapine augmented with caffeine using Swiss-albino mice
di: Alexis Danielle Y. Co, et al.
Pubblicazione: (2016-02-01)

Paroxetine versus other anti-depressive agents for depression
di: Purgato, M, et al.
Pubblicazione: (2014)

Brexpiprazole versus placebo or other antidepressive agents for treating depression
di: Ralovska, S, et al.
Pubblicazione: (2021)

Fluoxetine versus other types of pharmacotherapy for depression
di: Magni, L, et al.
Pubblicazione: (2013)

Atypical antidepressant mirtazapine inhibits 5-hydroxytryptamine3 receptor currents in NCB-20 cells
di: Yong Soo Park, et al.
Pubblicazione: (2023-02-01)

The Antidepressant Mirtazapine Rapidly Shifts Hepatic B Cell Populations and Functional Cytokine Signatures in the Mouse
di: Wagdi Almishri, et al.
Pubblicazione: (2021-03-01)

Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis.
di: Barbui, C, et al.
Pubblicazione: (2011)

Does mirtazapine enhance serotonergic neurotransmission in depressed patients?
di: Whale, R, et al.
Pubblicazione: (2000)

Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: systematic review, meta-analysis, and meta-regression analysis.
di: Cipriani, A, et al.
Pubblicazione: (2007)

Fluoxetine versus other types of pharmacotherapy for depression
di: Cipriani, A, et al.
Pubblicazione: (2009)

Fluoxetine versus other types of pharmacotherapy for depression.
di: Cipriani, A, et al.
Pubblicazione: (2005)

Are all antidepressants really the same? The case of fluoxetine: a systematic review.
di: Cipriani, A, et al.
Pubblicazione: (2006)